SCHEMBL22669692

SCHEMBL22669692

O=C(COc1ccc(F)cc1)NCC[C@H](O)CNC(=O)COc1ccc(F)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 2/20 0.48
WDR77 Q9BQA1 2/20 0.48
LMNA P02545 5/20 0.45
TP53 P04637 2/20 0.45
THRB P10828 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
GAA P10253 1/20 0.44
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MEN1 O00255 1/20 0.43
PPARG P37231 1/20 0.43
KMT2A Q03164 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
NR2E3 Q9Y5X4 1/20 0.43
NCOR2 Q9Y618 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20999090 1.00 PRMT5 (0.48) PRMT5WDR77LMNATP53THRB
SCHEMBL22669325 1.00 PRMT5 (0.48) PRMT5WDR77LMNATP53THRB
SCHEMBL22669244 0.95 HTT (0.47) PRMT5WDR77LMNASMN1; SMN2GAA
SCHEMBL20999707 0.95 HTT (0.47) PRMT5WDR77LMNASMN1; SMN2GAA
SCHEMBL22669409 0.92 LMNA (0.47) LMNATP53THRBSMN1; SMN2GAA
SCHEMBL20999725 0.92 PRMT5 (0.55) PRMT5WDR77LMNATP53THRB
SCHEMBL20999686 0.90 ATF4 (0.51) PRMT5WDR77LMNATP53THRB
SCHEMBL20999677 0.90 ATF4 (0.51) PRMT5WDR77LMNATP53THRB
SCHEMBL22669318 0.90 HPGD (0.49) PRMT5WDR77LMNATP53THRB
SCHEMBL22669489 0.90 HPGD (0.49) PRMT5WDR77LMNASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 PRMT5 2508/4885WDR77 2347/4885LMNA 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.